Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Key results at 80 weeks: Participants on the 4 mg dose lost an average of 47.2 lbs (19.0%) Participants on the 12 mg dose lost an average of 70.3 lbs (28.3%) 45.3% of participants on the 12 mg dose achieved at least 30% weight loss a level historically associated with bariatric surgery outcomes The 4 mg dose showed a lower rate of discontinuation due to adverse events than even placebo In a study extension to 104 weeks, participants with a starting BMI of 35 or higher who received 12 mg lost up to an average of 85.0 lbs (30.3%)
By contrast, pair-feeding causes less-pronounced weight loss, while weight matching requires a 51% decrease in food intake
M., Taylor, R
The Effect of Pentadecapeptide BPC 157 on Hippocampal Ischemia/Reperfusion Injuries in Rats
US$ 20.75
US$ 21.92
US$ 25.66
